Observational analyses from ADVANCE and ADVANCE-ON
Although the Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation (ADVANCE) study was designed as a multicentre randomised factorial placebo-controlled clinical trial, from the outset it was envisaged that the study would be extended to include observational analy...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2020
|